Fresenius kabi.to Acquire Medical Technology Company Ivenix

Fresenius Kabi（Bad Homburg）专门从事救生，输血和临床营养的救生药物和技术，同意收购Ivenix，Inc。（北侧和北坡，MA，USA），这是一家专业的输液治疗公司。欧廖斯的先进输液系统与弗雷斯妮乌斯·帕比的静脉内流体和输液治疗产品将为美国医院提供全面的输液产品组合。

伊万赛公司开发了一种技术先进的输液系统，包括大量泵（LVP），带有管理集，输液管理软件工具，应用程序和分析，以提供护理和提前效率。易于血液输液系统以患者和临床医生为中心，旨在减少与输液相关的错误并降低总体拥有成本。After having received the U.S. Food and Drug Administration’s (FDA) approval, the Ivenix Infusion System was launched in late 2021. The combination of Ivenix’ hardware and software products with Fresenius Kabi’s offerings in intravenous fluids and infusion devices will create a comprehensive portfolio of products for the growing infusion therapy market.

“We’re very pleased to partner with Fresenius Kabi, a leading global health care company. Together, we intend to transform the standard of care for North American health care providers and patients by providing the highest level of safe and effective integrated infusion care,” said Jorgen B. Hansen, Ivenix’s Chief Executive Officer.

“将伊万西克斯在泵技术和软件中与我们的基础设施，投资组合和在医院环境中的存在中相结合代表理想的机会。我们打算在推动美国的增长机会的同时扩展伊万西普的下一代输液系统的推出。凭借今天的公告，Fresenius Kabi预计培养领先的全面的输液治疗产品，“Fresenius Kabi总裁兼首席执行官Michael Sen说。

相关链接：
Fresenius kabi.
Ivenix, Inc.